Bristol Myers partners with Microsoft for AI-driven lung cancer detection

January 21, 2026
The collaboration will deploy U.S. Food and Drug Administration-cleared ‌radiology AI ‌algorithms through Microsoft’s Precision Imaging Network, which analyzes X-ray and CT ‌images to help identify lung disease and is used by hospitals in the United States, the companies said.